Explore the Global AI-based Clinical Trials Solution Provider Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

AI-based Clinical Trials Solution Provider Market

Key Insight

Oncology will lead AI-based clinical trials solution provider sales through 2036 with 31.7% of the therapeutic applications segment in 2026. The market was valued at USD 2.51 billion in 2025 and is expected to be worth USD 10.94 billion by 2036, creating an incremental opportunity of USD 8.07 billion.

May 11, 2026

Anurag Sharma

250 Pages

Cite this Report

AI-based Clinical Trials Solution Provider Market

https://www.futuremarketinsights.com/reports/ai-based-clinical-trials-solution-provider-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

AiCure LLC
Antidote Technologies Inc
BioAge Labs Inc
Deep 6 AI
Berkshire Hathaway
Innoplexus
International Machine Business Corporation (IBM)
Median Technologies
Mendel.ai
Saama Technologies Inc
Symphony AI
Unlearn.AI Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

AI-based Clinical Trials Solution Provider Market

Key Players

Similar Industry Reports